You just read:

Intas Pharmaceuticals Launches its Trastuzumab Biosimilar, Eleftha® - Further Bringing Down the Treatment Cost by 65%

News provided by

Intas Pharmaceuticals Limited

10 Apr, 2019, 16:06 IST